Your browser doesn't support javascript.
loading
Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19.
Borgoyakova, M B; Karpenko, L I; Merkulyeva, I A; Shcherbakov, D N; Rudometov, A P; Starostina, E V; Shanshin, D V; Isaeva, A A; Nesmeyanova, V S; Volkova, N V; Belenkaya, S V; Volosnikova, E A; Zadorozhny, A M; Orlova, L A; Zaykovskaya, A V; Pyankov, O V; Bazhan, S I; Ilyichev, A A.
Afiliação
  • Borgoyakova MB; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia. borgoyakova_mb@vector.nsc.ru.
  • Karpenko LI; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Merkulyeva IA; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Shcherbakov DN; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Rudometov AP; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Starostina EV; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Shanshin DV; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Isaeva AA; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Nesmeyanova VS; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Volkova NV; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Belenkaya SV; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Volosnikova EA; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Zadorozhny AM; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Orlova LA; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Zaykovskaya AV; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Pyankov OV; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Bazhan SI; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
  • Ilyichev AA; State Research Center of Virology and Biotechnology "VECTOR", Federal Service for the Oversight of Consumer Protection and Welfare, Koltsovo, Novosibirsk region, Russia.
Bull Exp Biol Med ; 174(2): 246-249, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36598669

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas de DNA / COVID-19 Limite: Humans Idioma: En Revista: Bull Exp Biol Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas de DNA / COVID-19 Limite: Humans Idioma: En Revista: Bull Exp Biol Med Ano de publicação: 2022 Tipo de documento: Article